DDB2 Suppresses Epithelial-to-Mesenchymal Transition in Colon Cancer

作者：Roy Nilotpal; Bommi Prashant V; Bhat Uppoor G; Bhattacharjee Shaumick; Elangovan Indira; Li Jing; Patra Krushna C; Kopanja Dragana; Blunier Adam; Benya Richard; Bagchi Srilata; Raychaudhuri Pradip^*

来源：Cancer Research, 2013, 73(12): 3771-3782.

DOI：10.1158/0008-5472.CAN-12-4069

Colon cancer is one of the deadliest cancers worldwide because of its metastasis to other essential organs. Metastasis of colon cancer involves a complex set of events, including epithelial-to-mesenchymal transition (EMT) that increases invasiveness of the tumor cells. Here, we show that the xeroderma pigmentosum group E (XPE) gene product, damaged DNA-binding protein (DDB)-2, is downregulated in high-grade colon cancers, and it plays a dominant role in the suppression of EMT of the colon cancer cells. Depletion of DDB2 promotes mesenchymal phenotype, whereas expression of DDB2 promotes epithelial phenotype. DDB2 constitutively represses genes that are the key activators of EMT, indicating that DDB2 is a master regulator of EMT of the colon cancer cells. Moreover, we observed evidence that DDB2 functions as a barrier for EMT induced by hypoxia and TGF-beta. Also, we provide evidence that DDB2 inhibits metastasis of colon cancer. The results presented here identify a transcriptional regulatory pathway of DDB2 that is directly linked to the mechanisms that suppress metastasis of colon cancer.

• 出版日期2013-6-15